Melinda Lillesand
Stavanger, 4021, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer.
Journal: Cancers
Published: February 01, 2026
Integrating Genetic Alterations and Histopathological Features for Enhanced Risk Stratification in Non-Muscle-Invasive Bladder Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: September 02, 2024
Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting prognosis of non-muscle invasive papillary urothelial carcinomas.
Journal: PloS one
Published: May 12, 2023
Automated Prognostic Assessment of Endometrial Hyperplasia for Progression Risk Evaluation Using Artificial Intelligence.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 20, 2022
High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling.
Journal: International journal of molecular sciences
Published: December 01, 2021
Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: November 23, 2020
A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment.
Journal: Cancer immunology, immunotherapy : CII
Published: September 30, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026